Nihon Kohden, a global leader in medical device innovation, enhances its neurological treatment capabilities by acquiring a majority stake in NeuroAdvanced Corp., the parent company of Ad-Tech Medical Instrument Corporation. This strategic move allows Nihon Kohden to combine its established expertise in EEG systems with Ad-Tech’s specialized intracranial electrodes, strengthening its ability to address complex neurological conditions, including drug-resistant epilepsy.